Molecular mechanisms generating the topographic organization of corticothalamic (CT) circuits, which comprise more than three-quarters of the synaptic inputs onto sensory relay neurons, and their interdependence with thalamocortical (TC) axon development are unknown. Using in utero electroporation-mediated gene transfer, we show that EphA7-mediated signaling on neocortical axons controls the within-nucleus topography of CT projections in the thalamus. Notably, CT axons that misexpress EphA7 do not shift the relative positioning of their pathway within the subcortical telencephalon (ST), indicating that they do not depend upon EphA7/ephrin-A signaling in the ST for establishing this topography. Moreover, misexpression of cortical EphA7 results in disrupted topography of CT projections, but unchanged inter-and intra-areal topography of TC projections. Our results support a model in which EphA/ephrin-A signaling controls independently the precision with which CT and TC projections develop, yet is essential for establishing their topographic reciprocity.
Introduction
Each area of the mammalian neocortex has a reciprocal connection with a unique set of thalamic nuclei, composing TC and CT projections that map topographically within their respective targets. Although much attention has focused on understanding the mechanisms involved in guidance of TC axons to their target in the cerebral cortex (Lopez-Bendito and Molnar, 2003) , very little is known about the mechanisms patterning reciprocal topographic CT projections. This lack of knowledge constitutes a major gap for two reasons. First, CT projections are approximately 10-fold more abundant than TC projections and comprise almost 50% of the synaptic input onto thalamic sensory relay neurons (Jones, 2002) . Second, there is increasing evidence indicating that feedback from the cortex plays a crucial role in modulating the thalamic responses required to perform the complex information processing and integration that underlie mammalian behaviors (Jones, 2002; Alitto and Usrey, 2003; Temereanca and Simons, 2004) . During development, CT axons grow ventrally within the intermediate zone of the neocortex, and make a sharp turn into the ST, where they meet TC axons growing in the opposite direction. Together, these early growing axons form the internal capsule (IC). CT axons emerge from the IC and turn dorsally at the junction between the telencephalon and diencephalon, projecting into the appropriate target thalamic nuclei (Miller et al., 1993; Molnar et al., 1998; Auladell et al., 2000) .
It has been hypothesized that growing CT and TC axons meet their counterparts within the IC and are guided to their targets through axon-axon interactions (Molnar and Blakemore, 1995; Molnar et al., 1998) . Recent evidence from the analysis of a variety of mutant mice is consistent with the hypothesis that normal growth and targeting of CT and TC projections depend on mutual interactions within the ST. For example, selective genetic deletion of transcription factors Tbr1, Gbx2, Pax6, or Emx1/2, which pattern the cortex or thalamus, results in aberrant pathfinding and failure to reach normal targets by axons originating from both the dorsal thalamus (DT) and cortex (Hevner et al., 2002; Bishop et al., 2003) . However, whether these interactions contribute only to the gross targeting of TC and CT projections or further to generate their topography is unknown.
Studies using mutant mice have not addressed the interdependence between TC and CT projections for regulating final topography. Cues in the cortex may contribute to areal targeting of TC axons (Bishop et al., 2000; Mallamaci et al., 2000; Zhou et al., 2001; Shimogori and Grove, 2005) . In some instances, such as the Emx2 and Dlx1/2 mutant mice, CT projections are also disrupted in the ST (Lopez-Bendito et al., 2002; Garel et al., 2002) . Ebf1 mutant mice exhibit mutually shifted TC and CT axons in the ST at embryonic day 16.5 (E16.5), but an initial normal trajectory of CT axons as they emerge from the cortex at E14.5 (Garel et al., 2002) . The role of reciprocal guidance is difficult to address using available mutant mice due to potential confounding factors such as the disruption of the terrain through which these axons traverse (e.g., Dlx1/2, Emx2 mutants), the severe defects that result in perinatal mortality, precluding analysis of the final targeting patterns of axons, and the lack of a strategy to differentially label TC and CT axons for analysis postnatally, when between-and within-region topography is clearly established. An alternative approach to investigate the strict interdependence of TC and CT axon guidance would be the direct and selective manipulation of axon guidance cues in one of the populations, but this has not been evaluated experimentally.
EphA receptors and their ligands, ephrin-As, serve as topographic labels in many circuits (Feldheim et al., 1998; Vanderhaeghen et al., 2000; Uziel et al., 2002; McLaughlin et al., 2003) . In the TC system, ephrin-A5 was shown to act as a repulsive cue for somatosensory TC axons expressing EphA receptors, and it appears to control the topography of TC projections within cortical areas (intra-areal topography) (Vanderhaeghen et al., 2000; Uziel et al., 2002) . Analysis of EphA/ephrin-A mutants suggests that ephrin-A5 signaling may also control the specificity of TC projections into individual cortical areas (interareal topography) by regulating the positioning of TC axons within the ST (Dufour et al., 2003) . Together with recent studies reporting the role of the ST in TC targeting (Garel et al., 2002; Seibt et al., 2003) , Dufour *Correspondence: pat.levitt@vanderbilt.edu et al. have raised a model that proposes that the guidance cues in the ST control the interareal specificity while intra-areal topography depends on cues within neocortex (Dufour et al., 2003) . Because EphA/ephrin-Atargeted mutations delete expression in the DT, ST, and cortex in the mice, the relative contributions of the cues in the ST versus cortex, or the contribution of the interaction between CT and TC axons on TC targeting, remain unknown. FGF8 misexpression studies in the cortical primordium imply that positional cues within the cortex, rather than within the ST, may independently determine the final interareal specificity of TC projections (Shimogori and Grove, 2005) . These misexpression studies, however, have not addressed whether the shift of TC projections depends on the guidance cues within the cortex or the interactions with CT projections, the characteristics of which also are likely to be shifted. In the present study, we investigated the role of EphA/ephrin-A signaling in the targeting of CT projections and examined whether there is a required interdependence between CT and TC axon targeting. We used in utero electroporation to alter the graded pattern of EphA7 expression selectively in the neocortex, thus excluding disruption of the cue in the ST or DT and allowing cortical axons overexpressing or underexpressing EphA7 to interact with normal ephrin-A cues. Our results define graded expression of EphA7 by neocortical neurons as a critical regulator of the topographic targeting of CT axons within thalamic nuclei and demonstrate the independence of this regulation from relative positioning of CT axons within the ST. Moreover, our results show that the topography of CT projections can be disrupted while the inter-and intraareal topography of TC projections develops normally. The data suggest that the final reciprocal circuitry can develop independently.
Results

Complementary Gradients of EphA7
and Ephrin-A5 Expression Expression patterns of EphAs in the DT and ephrin-As in the ST and cortex have been emphasized with respect to their roles in patterning of TC projections, but both receptors and ligands are expressed in multiple forebrain regions (Mackarehtschian et al., 1999; Yun et al., 2003; Bolz et al., 2004) . In particular, gradients of EphA7 and ephrin-A5 exhibit complementary expression patterns from embryonic to postnatal ages, consistent with putative molecular interactions during development. At early postnatal ages, when CT axons project into the DT and branch extensively (Frassoni et al., 1995) , there were robust EphA7 and ephrin-A5 complementary expression patterns within the neocortex and the DT (Figure 1 ). These patterns were already established at late embryonic ages, before large numbers of CT axons reach the DT (see Figure S2 available in the Supplemental Data available with this article online). EphA7 labeling was intense in neocortical layers II/III and V and was moderate in layer VI ( Figures 1A and 1B) . We noted that EphA7 expression in deep neocortical layers (layer VI and deep in layer V; Figures 1A and 1B) , from which CT axons originate, exhibited gradients complementary to those of ephrin-A5 expression in layer IV ( Figures 1D and 1E) , where TC axons mainly terminate. The gradients of EphA7 expression in thalamic nuclei ( Figure 1C ) such as the ventrobasal (VB) complex, which consists of the ventral posteromedial (VPM) and ventral posterolateral (VPL) nuclei, the medial division of the posterior nucleus (POm), the dorsal lateral geniculate nucleus (dLG), and the lateroposterior (LP) nucleus, were also complementary to those of ephrin-A5 ( Figure 1F ). Importantly, based on known reciprocal connectivity between the cortex and DT in the rodent, the gradients of EphA7 expression in deep neocortical layers were also complementary to ephrin-A5 gradients in their target thalamic nuclei (Figures 1A, 1B, and 1F) , and the gradients of EphA7 expression in thalamic nuclei were complementary to ephrin-A5 gradients in layer IV of their target cortical areas ( Figures 1C, 1D , and 1E). CT axons from the lateral part of S1 and the medial part of S2 (high EphA7 expression domain) project to the mediodorsal part of VB and the lateroventral part of POm (low ephrin-A5 expression domain) (Nothias et al., 1988; Fabri and Burton, 1991; Alloway et al., 2003) . On the other hand, CT axons from the medial part of S1 and the lateral part of S2 (low EphA7) project to the lateroventral part of VB and the mediodorsal part of POm (high ephrin-5) (Nothias et al., 1988; Fabri and Burton, 1991; Alloway et al., 2003) . Similarly, CT axons from the lateral (high EphA7) and medial (low EphA7) parts of the visual cortical area project to the medial (low ephrin-A5) and lateral (high ephrin-A5) (A-F) In situ hybridization for EphA7 (A-C) and ephrin-A5 (D-F) on coronal sections. EphA7 expression exhibits specific gradients in deep layers (layers V and VI) of S1 and S2 (A), visual (Vis) and auditory (Aud) (B) cortical areas, and thalamic nuclei (C). Ephrin-A5 is expressed in specific gradients in S1 and S2 (D), visual (E) cortical areas, and thalamic nuclei (F) complementary to EphA7 expression gradients. Gradients of EphA7 expression in the neocortex are also complementary to the gradients of ephrin-A5 expression in the thalamic nuclei (e.g., CT axons from the lateral part of S1 [high EphA7 expression domain] project to the mediodorsal part of VB [low ephrin-A5 expression domain], and CT axons from the medial part of S1 [low EphA7] project to the lateroventral part of VB [high ephrin-5]). Note the low ephrin-A5 in situ staining in the boundary region between POm and VPM, which exhibits an accumulation of CT axons from S1/S2 cortex (See Figures 4 and 5) . Triangles represent gradients of EphA7 in deep layers in (A) and (B) and of ephrin-A5 in layer IV in (D) and (E). Brackets indicate deep layers in (A) and (B) and layer IV in (D) and (E). Arrowheads denote boundaries between designated neocortical areas. Cytochrome oxidase (CO) staining was performed as a reference for cortical areas and layers and thalamic nuclei (Figure S1 ). Scale bars, 300 mm.
Neuronregions of the dLG, respectively (Lozsadi et al., 1996) . Reciprocal TC axons from each thalamic nucleus project topographically to the specific cortical area (Carvell and Simons, 1987; Nothias et al., 1988; Fabri and Burton, 1991; Deschenes et al., 1998) .
We next performed human Fc-tagged ephrin-A5 and EphA7 binding histochemistry to investigate the distribution of their receptor and ligand proteins, respectively ( Figure S3 ). Distribution of the receptor for ephrin-A5, indicated by ephrin-A5-Fc binding, exhibited graded patterns in the neocortex and the DT. These patterns appeared similar to those of EphA7 mRNA expression ( Figures 1A-1C) . We also noted that ligand distribution for EphA7 in the neocortex and the DT, as indicated by Eph-A7-Fc binding, was similar to that distribution in those regions for ephrin-A5 mRNA ( Figures 1D-1F ). The ligand binding and receptor binding data, together with the in situ hybridization patterns, demonstrate that EphA7 and ephrin-A5 are expressed in complementary gradients within, as well as between, specific neocortical areas and their respective thalamic nuclei. These findings are consistent with the hypothesis that EphA7 and ephrin-A5 are receptor and ligand partners in vivo.
Neocortical Layer Organization Is Not Disrupted by EphA7 Overexpression
Due to the complex expression patterns described above, the precise guidance role unique to CT patterning is difficult to distinguish in EphA and/or ephrin-A mutant mice; the constitutive knockouts will exhibit altered expression and interrelated defects in the DT, ST, and cortex, and appropriate floxed lines do not exist. In order to overcome this problem, we used in utero electroporation. Mouse embryos were electroporated at E12.5, a period well before the elaboration of CT axons, and the projections of CT and TC axons were analyzed at postnatal stages.
EphA7 or control plasmid DNA was cotransfected with an enhanced yellow fluorescent protein (EYFP) expression plasmid as a marker for the electroporated neocortical domains. In control (data not shown) and EphA7-electroporated brains, transferred gene expression was detected in both subplate neurons, which are born from E11.5 to E13.5, and later-born cortical plate neurons (Takahashi et al., 1999; Hevner et al., 2003) , consistent with the stage of electroporation at E12.5 ( Figure 2A) .
We first analyzed parameters of cortical development to eliminate the possibility that any disruption of CT axonal patterning was due to aberrant formation of the neocortex proper following EphA7 electroporation. Several lines of evidence indicate that cortical development proceeded normally. First, we did not observe any layerspecific accumulation of EYFP + cells with ectopic EphA7 expression (Figure 2A ), and DAPI staining showed no obvious disruption of neocortical layers in electroporated regions ( Figure 2B ). Second, cresyl violet staining showed that radial positioning of EphA7-transfected cells was normal, and no aberrant layer patterning was observed in the electroporated regions ( Figures 2C and  2D ). Third, we examined the expression patterns of two different transcription factors that serve as markers of specific layers-FoxP2 (Ferland et al., 2003) and Oct6 (also known as SCIP or Tst-1) (Frantz et al., 1994) . Patterns of FoxP2 expression in layer VI ( Figure 2E ) and Oct6 expression in layers II/III and V ( Figure 2G ) were normal throughout the cortex, including regions containing the EphA7-transfected cells (Figures 2F and 2H) . Thus, overexpression of EphA7 in restricted regions of the cerebral wall during prenatal development does not cause disruption of the patterning of emerging neocortical layers postnatally.
Overexpression of EphA7 Shifts Topographic Targeting of CT Projections
Next, we analyzed the projections of CT axons in EphA7-electroporated brains. For these experiments, EphA7 or control plasmid DNA was mixed with a high concentration of DsRed2 expression plasmid and a low concentration of EYFP expression plasmid (see Experimental Procedures). We confirmed that EYFP + /DsRed2 + cells in the neocortex and axons in the ST express higher levels of ectopic gene expression relative to EYFP results is consistent with a previous study demonstrating the correlation between relative intensities of green fluorescent protein (GFP) and DsRed2 fluorescence in brains in which expression plasmids for both markers were electroporated (Hatanaka et al., 2004) . Thus, transferring these two different markers at specific concentrations enabled us to compare differential projection patterns between CT axons with higher (EYFP + /DsRed2 + : yellow; designated EYFP + axons) and lower to no (EYFP 2 / DsRed2 + : red; designated EYFP 2 axons) levels of ectopic gene expression originating from the same cortical region (indicated in Figure 3J ). The overall labeling scheme using electroporated markers allowed the tracing of the different subsets of CT axons from the neocortex to the thalamus ( Figure S4 ), without the need for exogenous application of dyes, which can confound analysis because both CT and TC axon populations are labeled. Ectopic genes were transferred into distinct cortical areas by controlling the placement of the electrodes ( Figure S4 ). In mice electroporated with control constructs in S1/S2 regions, EYFP + and EYFP 2 CT axons were organized normally in VB and POm ( Figures 4A-4C ) at P4, accumulating in topographically appropriate regions along the dorsomedial-ventrolateral axis in VB and POm (arrowheads), with an additional boundary region (POm/VPM) of dense innervation (Nothias et al., 1988; Fabri and Burton, 1991; Deschenes et al., 1998; Alloway et al., 2003) . This POm/VPM boundary region has the lowest expression of ephrin-A5 (see Figure 1F ). In EphA7-electroporated brains, however, the majority of EYFP + (increased levels of EphA7) axons failed to distribute correctly within their target nuclei, instead coalescing heavily at the border region between VB and POm, where ephrin-A5 expression is the lowest ( Figure  4E , arrow; compare to Figure 1F ). In contrast, EYFP 2 (relatively normal levels of EphA7) axons entered and distributed normally within these nuclei ( Figure 4F , arrowhead). In control brains electroporated without the EphA7 construct, such distinctions between EYFP + and EYFP 2 axons never were observed ( Figures 4A-4C ). A similar disruption of CT axon patterning was evident when ectopic gene expression was targeted to visual cortical areas ( Figures 4G-4L ). We analyzed CT patterning in LP because most cases of ectopic EphA7 expression included only secondary visual areas, which project mainly to LP. In control brains, CT axons entered normally into LP at P4 (Figures 4G-4I ). In contrast, in EphA7-electroporated brains, the majority of EYFP + CT axons accumulated at or just across the junction between dLG and LP, where ephrin-A5 expression is low (Figure 4K , arrow; compare to Figure 1F ), whereas EYFP 2 CT axons extended into LP ( Figure 4L , arrowhead). Overall, the topographic targeting of EphA7-overexpressing CT axons shifted to domains near or within thalamic targets where ephrin-A5 levels are low.
Decreasing EphA7 Causes a Shift of CT Projections Inverse to the Pattern Observed in Overexpression
To provide additional evidence that neocortical EphA7 is involved in CT axon patterning, EphA7 siRNA was electroporated at E12.5 to reduce endogenous expression levels of EphA7 in the cortex. Activity and specificity of the siRNA in vivo was confirmed by decreased EphA7 mRNA expression ( Figures 5A-5F) ; there was no effect on expression of EphA5, another gene of the EphA family (data not shown). As noted for overexpression of EphA7, siRNA-mediated reduction of EphA7 expression in the somatosensory areas did not cause disruption of neocortical layer patterning (data not shown), but did result in a clear shift in the mapping of CT projections in a manner inverse to that observed following EphA7 overexpression. Thus, EYFP + (here, indicating decreased levels of EphA7) CT axons were segregated from EYFP 2 (relatively normal levels of EphA7) axons, with the former distributing into more ventrolateral regions that express higher levels of ephrin-A5 (Figures 5J-5L ; compare to Figure 1F ). In control siRNA-electroporated brains, such axonal segregation never was observed ( Figures 5G-5I ). These disparities in CT axon mapping, caused by overexpression and reduction of EphA7, were even more prominent at P12, when the pattern of terminal arborizations approaches maturity ( Figure 6 ).
While the qualitative patterns of CT axon distribution suggest a vital role for EphA7 in within-nucleus targeting, we performed quantitative analysis in order to demonstrate both experimental reproducibility and the extent to which altering levels of EphA7 expression by neocortical neurons can impact CT development. Computer-based rotation of the axonal distribution pattern in each animal facilitated quantitative analysis of the distribution of labeled axons across POm and VB ( Figure 5M ; see Experimental Procedures in detail). The data demonstrate that there was a statistically significant, inverse shift in CT axon targeting, compared to control, between EphA7 overexpression and inhibition in S1/S2 cortex ( Figure 5N ). In normal and EphA7-manipulated brains, subpopulations of CT axons accumulated at the POm/ VPM boundary, within the region of the lowest ephrin-A5 expression. The dense innervation of this border region is seen in the normal adult thalamus (Deschenes et al., 1998) . The quantitative analysis clearly revealed a strong shift of CT projections toward the POm/VPM boundary due to EphA7 overexpression ( Figure 5N , green bars) and a shift toward the more lateral region around the VPM/VPL boundary due to reduced EphA7 expression ( Figure 5N , black bars). These results show that EphA7 expressed on afferents contributes to CT topographic map formation, and they are consistent with CT axons that arise from sensory neocortical regions using the complementary gradients of ephrin-A5 in thalamic nuclei as topographic labels.
EphA7-Mediated Control of CT Axon Targeting Does Not Involve the Positional Control of CT Axons within the ST Recent studies suggest that the topography of TC projections may not be strictly determined by cues located within the neocortex proper, but rather may be regulated by the relative positioning of thalamic axons within the ST (Garel et al., 2002; Seibt et al., 2003) . Ephrin-A5 expressed in the ST appears to control this positioning (Dufour et al., 2003) . Similarly, the altered CT mapping that we observed by changing EphA7 levels in neocortical neurons could result from altered positioning of CT axons responding to ephrin-A5 at the ST. To investigate this possibility, we analyzed the distribution of normal and EphA7-overexpressing CT axons within the ST of EphA7-electroporated brains. In all cases in which EphA7 was electroporated into somatosensory or visual cortex (n = 13), there were no obvious differences in the positioning of EYFP + and EYFP 2 CT axons in the ST, but rather, the populations completely intermingled, even within a single bundle level (Figure 7 ). To determine if there were more subtle shifts, we quantitated the influence of EphA7 overexpression on the positioning of CT axons in the ST by plotting the distances of the weight center of EYFP + axons from that of DsRed2 + axons in cross-sections around the exit point of the IC, where the guidance within the ST should be reflected (Figure 7D; see Experimental Procedures for details). The analysis shows that there were no shifts in the distribution of EYFP + axons compared to DsRed2 + axons along both anteroposterior and ventrodorsal axes ( Figure 7D , right panel). These data indicate that CT axons do not use the ST-located ephrin-A5 repulsive cue in the same fashion as TC axons, and thus the CT mapping shifts that we observed in the DT do not result from positional shifts of these axons in the ST.
The Shift of CT Axon Targeting Is Independent of TC Axon Targeting Because positioning of EYFP + and EYFP 2 CT axons within the ST in EphA7-electroporated brains is the same as in controls, these two populations likely encounter the same sets of TC axons in the IC. Formally, however, there was still a possibility that the shift of EYFP + CT axons in the thalamus would be paralleled by a spatially matched shift of TC axon counterparts. To test this possibility, we first examined the overall pattern of TC projections at E18.5 in EphA7-electroporated brains by immunohistochemistry for netrin-G1, which selectively labels TC axons (Nakashiba et al., 2002) (Figures 8A-8F) . The trajectory of netrin-G1 + TC projections, visualized from the DT to the cortex on the electroporated side, was identical to that on the control side. At a gross level, within the ST, TC axons were mingled with CT axons, including EYFP + axons, without any unusual crossing or divergence ( Figure 8D ). In the cortex, netrin-G1 + axons followed a normal subcortical pathway, and fasciculation and ingrowth into the cortical plate ( Figures 8E and 8F ) were identical to those on the control side.
While gross patterning was unchanged, we performed two other studies to examine the topographic patterning of TC projections. First, analysis of the bilateral TC connectivity in brains electroporated with EphA7 in the S1 area was done, using superficial DiI (1,1 0 -dioctadecyl-3,3,3 0 ,3 0 -tetramethylindocarbocyanine perchlorate) injections into the electroporated region of S1 and the homotopic contralateral area. In all cases examined (n = 5), TC axons and thalamic neurons within VB and POm were retrogradely labeled, corresponding to the region in which the DiI crystals were placed within S1, without any difference between the electroporated and control sides of the thalamus (Figures 8G and 8H ; Figure S5 ). In no animals did we observe ectopic accumulation of labeled thalamic neurons around the border of VB and POm, as was seen for EphA7-overexpressing CT axons in the same brains ( Figure 8I ; Figure S5 ). Thus, the shift in CT mapping was not associated with a matching shift of TC projections to S1 cortex.
The single labeling paradigm demonstrates normal interareal topography. In order to determine further whether there were any topographic shifts of TC axons that innervated different subfields of the same area of EphA7-electroporated S1 neocortex, we placed DiI and DiA (4-(4-(dihexadecylamino)styryl)-N-methylpyridinium iodide) superficially at medial and lateral aspects of S1, located within the domain in which ectopic EphA7 is expressed ( Figure 8J ). DiI-and DiA-labeled TC axons were traced along parallel pathways in the ST without any obvious shifts in topography (n = 3). In fact, both DiIand DiA-labeled axons were intermingled with EYFP + CT axons ( Figure 8K ). Moreover, there was normal topographic distribution of retrogradely labeled DiI and DiA neurons within VB ( Figure 8L : DiI-labeled medial VB neurons project to lateral S1 [red]; DiA-labeled lateral VB neurons project to medial S1 [blue]). These data collectively demonstrate that TC axons intermingle with CT axons that overexpress EphA7, and, in addition, their inter-and intra-areal topography is normal even when EphA7 is overexpressed in a neocortical target region.
Discussion
The present study demonstrates that the gradient of EphA7 receptor levels expressed by neocortical neurons controls the topography of CT projections through local interactions within individual thalamic nuclei. Moreover, this EphA7-mediated mapping is independent both of the relative positioning of CT axons in the ST and the topographic mapping of TC projections.
Topographic Mapping of CT Axons by EphA7-Mediated Signaling within Thalamic Nuclei
The strategy of using in utero electroporation prior to CT and TC development provides an approach to modulate EphA7 expression levels selectively in specific regions of the neocortex. Our data demonstrate a precision in the shift in topographic mapping of CT projections within thalamic nuclei. The shift depends upon the relative levels of EphA7 expression by neocortical neurons and is highly predictable and reproducible based on the distribution of the putative complementary ligand, ephrin-A5. Our demonstration of ephrin-A5-Fc binding to axons overexpressing EphA7 supports their mutual binding activity in vivo. The expression patterns of EphA7 and ephrin-A5 are highly complementary in the neocortex and DT and are similar to ephrin-A5-Fc and EphA7-Fc binding patterns, respectively. These patterns are consistent with our hypothesis that ephrin-A5 serves as a dominant ligand in vivo for EphA7 among combinatorial gradients of ephrin-As. This also is consistent with the evidence that ephrin-A5 selectively binds EphA7 in the lysates of postnatal striatal tissue (Janis et al., 1999) .
The molecular basis of EphA7-mediated mapping of CT projections by ephrin-As may occur by the relative sensitivity of CT axons, defined by comparative levels of EphA7 receptor expression, to ephrin-A cues within thalamic nuclei. Such a mechanism has been suggested by genetic studies of mouse retinocollicular topography, in which relative levels of expression of EphA receptors on neighboring retinal ganglion cells mediate the repulsive ephrin-A signaling and control nasotemporal topography through axon competition (Brown et al., 2000; Reber et al., 2004) . Map formation also could be mediated by other mechanisms. For example, CT axons that express different levels of EphA7 receptors may exhibit differential sensitivity to ephrin-A concentrations, resulting in a ligand concentration-dependent shift from positive to negative responses in axon growth (Hansen et al., 2004) . This model supports the hypothesis that the reciprocal topography of CT and TC axons might be determined by their specific interaction in the ST (Molnar and Blakemore, 1995; Molnar et al., 1998) . These studies, however, used mutant mice that were early lethal, or in which the disrupted genes were expressed in some combination of the DT, ST, and neocortex. This precludes analysis of the relative contributions of the ST, neocortex, or the interaction between TC and CT axons, to the final topography of TC projections. Our results show that EphA7-mediated CT axon targeting is independent of the positioning of their pathways within the ST and any concomitant change in TC projection topography. They provide evidence that the regulation within the DT itself plays a central role in establishing the topography of CT projections within each nucleus. Our data do not address the issue of whether between-nuclei specificity of CT projections is controlled by their positioning in the ST. The more gross organization of CT axons may depend upon specific interaction with TC projections, though this remains to be formally tested with specific candidate molecules.
Topographic Targeting of CT Projections
Our results demonstrate a definitive difference between guidance mechanisms for CT and TC projections. Lack of disruption of CT axons in the ST by altering EphA7 expression levels contrasts with the shift of TC projections in the ST of EphA and/or ephrin-A mutants (Dufour et al., 2003) . While the axons clearly overexpress EphA7 as they grow through the ST, the absence of a shift suggests that growing CT axons, as they pass through the ST, are unresponsive to the gradients of ephrin-As until they reach the thalamus. Alternatively, other guidance molecules, or some other Eph/ephrin combination, may have stronger effects to restrict the pathway of CT axons within the ST.
The present study formally tested whether disruption of TC and CT circuits can occur independently. We note that our formal model of differential control of CT and TC guidance is consistent with the report of normal emergence of CT axons from the cortex in the Ebf1 knockout mice at E14.5 while, at the same time, TC axons enter the ST abnormally (Garel et al., 2002) . However, those authors' analysis of CT axons was only performed until E16.5, and, in fact, they reported shifting of CT and TC elements in the DT proper at E16.5. It is important to note that this period of fetal development is prior to the establishment of the topography of CT projections in the DT targets. Thus, while Garel et al. suggested a possibility that a displacement in TC axons, and in the alignment of TC and CT axons, can induce a shift in the neocortex as well as a reciprocal shift in CT projections, if TC and CT axons do directly interact, the time period to evaluate this was not examined. Our results demonstrate that CT innervation in the DT can shift even in the context of normally projecting TC neurons, which is likely to lead to a disruption of physiological reciprocity between them. The functional impact of this mismatch, given the role of reciprocal CT input in sensory map precision (Temereanca and Simons, 2004) , will be of interest to investigate.
How does the model of independent guidance mechanisms for developing CT and TC topography fit with the neuroanatomical organization of these developing circuits? CT and TC axons coalesce along similar pathways in the ST during development (Miller et al., 1993; Molnar et al., 1998; Auladell et al., 2000) , and the most constricted point for both CT and TC axons is the boundary between the diencephalon and the telencephalon. However, each axon population approaches this shared boundary with a unique organization. CT axons approach this region after they pass the ST, already sorted, whereas TC axons come to this point before they pass through the ST. Thus, the correct sorting of TC axons in the ST, prior to reaching their putative cortical targets, is likely to be of more significance than it would be for CT axons, which require sorting after crossing the diencephalon-telencephalon boundary. For between-nuclei sorting of CT projections, the thalamic reticular nucleus, (J-L) Triple labeling with DiI (red) and DiA (blue) and EYFP immunostaining (green) to examine the within-area topography of TC projections to S1 cortex. DiI and DiA crystals were inserted superficially into the lateral and medial aspects of the EYFP + EphA7-electroporated S1 region, respectively (J). EYFP + CT axons are associated with DiI and DiA labeled TC axons projecting in parallel within the ST (K), whereas their terminal axons within VB/POm were topographically segregated from retrogradely labeled clusters of TC neurons (L). Note that the intra-areal topographic relationship of DiI and DiA labeled TC neurons at the medial and lateral region of VB to project to the lateral and medial part of S1 is normal as described (Carvell and Simons, 1987; Nothias et al., 1988; Fabri and Burton, 1991; Deschenes et al., 1998) . Scale bars, 300 mm (A-C, G-I, J, and L); 200 mm (D-F), and 100 mm (K).
which is situated just before the DT, is an interesting candidate for a role similar to that of the ST for the guidance of TC projections (Mitrofanis and Guillery, 1993; Adams et al., 1997) , and there are guidance cues expressed in this region that can be tested formally (Skaliora et al., 1998; Marillat et al., 2002) .
The Role of EphA/ephrin-A Signaling in the Reciprocal Organization of CT and TC Projections How can TC and CT projections achieve their reciprocal organization without interdependent controls? Based on the present results and studies suggesting that the intra-areal topography of TC projections is regulated by an EphA gradient in thalamic nuclei and an ephrin-A gradient in target cortical areas (Vanderhaeghen et al., 2000; Dufour et al., 2003) , we propose a model in which complementary gradients of EphA and ephrin-A activity, located between as well as within specific cortical areas and their corresponding thalamic nuclei, produce reciprocal signaling between these structures. In our model, however, the EphA/ephrin-A signaling controls the topography of TC and CT projections independently, yet establishes essential functional topographic reciprocity (Figure 9 ).
In this model, functional gradients of EphA receptors and ephrin-A ligands are required to be complementary both between and within each reciprocal target. Specific expression patterns of EphAs and ephrin-As appear before CT and TC axons reach their targets (Sestan et al., 2001; Mackarehtschian et al., 1999; Yun et al., 2003; Bolz et al., 2004) . Together with recent evidence for intrinsic regulation of EphA7 and ephrin-A5 expression within the neocortex by transcription factors or morphogens (Miyashita-Lin et al., 1999; Bishop et al., 2002; Shimogori and Grove, 2005) , gradients of EphAs and ephrin-As are likely established by intrinsic regulation within the neocortex and DT independently. Complementary patterns might be achieved by reciprocal transcriptional regulation for each by the same transcription factor. For example, in dorsoventral patterning of the retina, Tbx5 enhances transcription of ephrin-Bs and represses EphBs (Koshiba-Takeuchi et al., 2000) . In contrast, Vax2 enhances the transcription of EphBs and represses ephrin-Bs (Barbieri et al., 2002; Mui et al., 2002) . In addition to transcriptional regulation, repressive modulation of EphA function by coexpressed ephrin-A, as shown on retinal ganglion cell axons (Hornberger et al., 1999) , might sharpen their functional complementarity where their expression overlaps. Reciprocal and topographic neural connections are found in many other systems throughout the brain. It will be important to determine whether this independent, but reciprocal, EphA/ ephrin-A signaling model is applicable generally to other systems.
Experimental Procedures Animals
Embryos and pups were obtained from timed pregnant CD-1 mice (Charles River). Noon of the day on which a vaginal plug was observed and the day of birth are designated as embryonic day 0.5 (E0.5) and postnatal day 0 (P0), respectively. All experiments using animals were approved by the Animal Care and Use Committee at Vanderbilt University.
In Situ Hybridization
In situ hybridization on 25 mm cryosections was performed as described (Grove et al., 1998) . Probes for EphA5 (975 bp rat partial clone), EphA7 (1014 bp rat partial clone), and ephrin-A5 (rat fulllength clone) were kind gifts from L. F. Kromer. The probe for cadherin-8 is a kind gift from C. Redies (Korematsu and Redies, 1997) . For double staining with EYFP, signal was visualized using the HNPP Fluorescent Detection Set (Roche), followed by EYFP immunohistochemistry as described below. Whole-mount in situ hybridization was performed as described (Suzuki et al., 1997) .
Histology and Immunohistochemistry
Brains were fixed with 4% paraformaldehyde overnight. For immunohistochemistry on brain slices, 75 mm vibratome slices were collected. Slices were incubated with polyclonal anti-GFP antibody (1:3000; Molecular Probes or 1:1000; Abcam), followed by incubation with HRP-conjugated secondary antibody (1:1000; Jackson Immunoresearch) and TSA Fluorescence System (PerkinElmer). For double immunohistochemistry for EYFP and DsRed2, slices were then incubated with polyclonal anti-DsRed antibody (1:5000; BD Biosciences), followed by incubation with HRP-conjugated secondary antibody, TSA Biotin System (PerkinElmer), and avidin-conjugated Cy3 (1:1000; Jackson Immunoresearch). Slices were counterstained with DAPI (Molecular Probes).
For double immunofluorescent staining, 20 mm cryosections were incubated with polyclonal anti-FoxP2 (1:1000; Novus Biologicals), anti-Oct6 (1:1000; Santa Cruz), or anti-netrin-G1 (a kind gift from S. Itohara) antibody, mixed with anti-GFP antibody (1:1000; Abcam), followed by incubation with biotin-conjugated secondary antibody and avidin-conjugated Cy3 and then with HRP-conjugated secondary antibody and TSA Fluorescence System. Immunoperoxidase staining on sections was performed on 20 mm cryosections as described (Torii et al., 1999) . Cresyl violet staining was performed following a standard protocol. CO histochemistry was performed on 25 mm cryosections as described (Wong-Riley, 1979) . Slices and sections were photographed with a CCD camera on an Axoplan2 microscope or an LSM510 confocal microscope (Carl Zeiss).
Ligand Binding and Receptor Binding Histochemistry
Ligand binding and receptor binding histochemistry on 20 mm cryosections was performed as described (Janis et al., 1999) . Recombinant human ephrin-A5/Fc or EphA7/Fc chimeric protein (R&D Systems) binding sites were visualized using the TSA Biotin System and avidin-conjugated Cy3 or Cy5 (1:1000; Jackson Immunoresearch). After visualization, some sections were treated with the Figure 9 . Model Depicting the Control of Reciprocal Organization of CT and TC Projections by EphA/ephrin-A Genes EphAs and ephrin-As are expressed in complementary gradients (indicated by blue and red triangles, respectively) within and between specific neocortical areas and their respective thalamic nuclei. TC and CT axons with high (solid lines) and low (dashed lines) levels of EphAs project to the domains with low and high levels of ephrin-As, respectively, within their targets. The projection topography is controlled independently within the DT and the neocortex, yet each structure establishes reciprocal connections.
ABC blocking kit (Vector), followed by EYFP and DsRed2 immunohistochemistry.
Expression Plasmids and siRNAs for Electroporation IRES-EGFP (BD Biosciences) was inserted into pCAGGS vector (Niwa et al., 1991) as a control plasmid (pCAG-IRES-EGFP). Fulllength cDNA of rat EphA7 (a gift from L. F. Kromer) followed by IRES-Venus (EGFP was replaced to Venus [Nagai et al., 2002] , a variant of YFP [a gift from A. Miyawaki]) was inserted into pCAGGS as the EphA7-expression plasmid (pCAG-EphA7-IRES-Venus). DsRed2 (BD Biosciences) was inserted into pCAGGS as a reporter plasmid (pCAG-DsRed2). pCAG-EYFP was provided by T. Saito. The double-stranded EphA7 siRNA was predesigned by Ambion (siRNA ID, 103405; Ambion: sense: GGAUAACUAUGUCACUGUCtt, antisense: GACAGUGACAUAGUUAUCCtc). A nonspecific siRNA (Silencer Negative Control #1 siRNA; Ambion) was used as a negative control.
In Utero Electroporation
In utero electroporation was carried out at E12.5 as described (Tabata and Nakajima, 2001; Saito and Nakatsuji, 2001) . DNA solutions of pCAG-EphA7-IRES-Venus (2 mg/ml), pCAG-IRES-EGFP (2 mg/ ml), EphA7 siRNA (0.5 mg/ml), or control siRNA (0.5 mg/ml) were injected, with a higher concentration of pCAG-DsRed2 (3 mg/ml), which labels all transfected cells, and a lower concentration of pCAG-EYFP (0.5 mg/ml) to label only the subpopulation with high levels of ectopic gene expression. Brains from embryos or pups were collected and photographed using a CCD camera (Carl Zeiss) on a MZFLIII fluorescent stereomicroscope (Leica). The numbers of electroporated brains analyzed for S1/S2-VB/POm topography were: EphA7, 9 (P4) and 6 (P12); control plasmid or siRNA, 12 (P4) and 3 (P12); and EphA7 siRNA, 4 (P4) and 4 (P12). The numbers of brains for visual-LP topography were: EphA7, 4 (P4) and 2 (P12); and control plasmid, 5 (P4) and 1 (P12). There were a few cases in which exogenous gene expression occurred in the ST and cortex, but not in the DT. Brains in which exogenous gene expression occurred only within the cortex were analyzed.
Quantification of Areas Occupied by CT Axons
The spatial shift of EYFP + CT projections by altered EphA7 expression levels was measured in coronal sections through the DT as follows ( Figure 5M ). Slices were collected from brains electroporated (control: n = 5, EphA7 EP: n = 5, and EphA7 siRNA EP: n = 4) in S1 and/or S2 among all electroporated brains analyzed (some of which were also electroporated into frontal and nonsomatosensory areas, which we excluded from the quantitative analysis.). A similar distribution of EYFP 2 CT projections within VB and POm at the same coronal level was confirmed (for example, see EYFP 2 labeling in Figures  4C, 4F , 5I, and 5L). We divided VB and POm anatomically into 30 bins vertical to the mediodorsal-to-lateroventral axis of the nuclei. The area occupied by EYFP + CT axons in each bin was measured using Scion Image (Scion Corporation) and normalized to the total area occupied by EYFP + CT axons in the entire VB and POm to obtain the percentage distribution (area-fraction) along the designated axis through the nuclei. The slides were coded so that the investigator was blind to the electroporation condition. Repeated Measures AN-OVA was performed using SPSS (SPSS Inc.).
Quantitative Analysis of the Distribution of CT Axons
In four brains electroporated in the cortex with the EphA7 plasmid, X (anterior to posterior) 2 Y (ventral to dorsal) axial positions of DsRed2 + and EYFP + CT axon bundles in cross-sections around the exit point of the IC were measured on confocal images using Scion Image. Areal weight centers of DsRed2 + and EYFP + CT axons were calculated using Excel (Microsoft). The distance of the center of EYFP + axons from that of DsRed2 + axons was determined by setting the coordinates of the center of DsRed2 + axons to (0, 0) and plotted onto the scatter plot.
Axonal Tracing
A small crystal of DiI (Molecular Probes) was inserted with a fine needle into the superficial layers of P4 electroporated neocortex fixed with 4% paraformaldehyde in PBS. The sites of injection were the middle of the EYFP + S1 region, visualized under fluorescent illumination with a MZFLIII stereomicroscope, and the corresponding region in the nonelectroporated contralateral side as a control. After storage in fixative for 3 to 4 weeks in the dark at 37ºC, 75 mm vibratome slices were collected, and EYFP immunohistochemistry was performed. The superficial DiI injection predominantly labels TC axons retrogradely from cortical layer IV to their cell body in the DT, and not CT axons anterogradely from layer VI (see Figures 8G-8L ). For triple labeling with DiI and DiA and EYFP immunostaining, each crystal was inserted into the dorsal and ventral region within the EYFP + S1 region, and EYFP immunohistochemistry was performed using avidin-conjugated Cy5.
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